DIBIASE MARY (Chief Operating Officer) sold 1.8% of their position (2.64K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $3.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/12/2023ACC: 0001628280-23-032065
Officer· Chief Operating Officer
Since Sep 2021
-2.64K
Net shares
Net seller
$3.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.64K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.64K
Price / share
$1.25
Trade value
$3.30K
% of position
1.8%
9/8/2023
150.54K→147.89K
Total
Net shares
−2.64K
Net value
-$3.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/8/2023 | S · Sale | −2.64K | $1.25 | $3.30K | 1.8% | 150.54K | 147.89K |
| Total | −2.64K | -$3.30K | ||||||
Derivative Transactions0
No derivative transactions reported